1875 Explorer Street, Suite 800
Reston, VA 20190
Full-service IP firm: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the world’s largest firms focusing exclusively on IP. It is a true one-stop shop for all IP matters, with experts in every area of IP and every technology. A comprehensive approach to clients IP needs and Finnegan’s mega-boutique size underpin its year-to-year, decade-to-decade pre-eminence in IP litigation across all industries and tribunals.
Global presence: The firm’s offices in the United States, Asia, and Europe practise all aspects of patent, trademark, copyright and trade secret law. Its multinational team represents clients on IP issues relating to U.S. and European patent and trademark law, international trade, portfolio management, the Internet, cybersecurity, e-commerce, government contracts, antitrust and unfair competition.
Industry and technical expertise: Finnegan offers full-service IP legal and technical experience in virtually every industry and technology: biotechnology, pharmaceuticals, biologics and biosimilars, combination products, chemicals, oil and gas, electronics, semiconductors, computers and software, FinTech, Internet of Things (IoT), automotive, aerospace and aviation, industrial manufacturing, consumer products, food and beverage, outdoor recreation, sports and fitness, digital health, medical devices, clean energy and renewables, robotics, textiles, artificial intelligence (AI), and 3D printing.
IP-focused talent: With Finnegan’s practice centred on intellectual property, the firm is positioned to create economies of scale and focus all resources on providing the best tools and teams for clients. In the past five years, Finnegan filed over 650 IP-related district court cases. The firm’s team is comprised of over 250 litigators, including career trial attorneys. Over 300 of Finnegan’s legal professionals hold degrees in scientific disciplines (more than 60 hold PhDs). Over 225 professionals are registered to practise before the US Patent and Trademark Office (USPTO), European Patent Office (EPO), the German Patent and Trade Mark Office (DPMA), the UK Intellectual Property Office (UKIPO), and the European Union Intellectual Property Office (EUIPO).
ANDA litigation: Since being involved in the very first ANDA litigation, Finnegan has been a leading firm representing innovative pharmaceutical companies before federal district courts and the U.S. Court of Appeals for the Federal Circuit. Our successes derive from a deep bench of experienced and technically sophisticated attorneys who understand the long-term plans of innovative pharmaceutical companies as well as the legal particularities of ANDA litigation under the Hatch-Waxman Act and the nuances of pharmaceutical patent law. Over the last five years, our attorneys have represented more than 20 brand companies in almost 400 ANDA litigations involving revolutionary drugs such as Brilinta®, Farxiga®, Relistor®, Jublia®, Aptiom®, Injectafer®, and Abilify®. We consistently have 150+ ongoing ANDA litigations every year, providing counselling and litigation services in a range of technologies such as antibodies, automated DNA sequencing, diagnostics, imaging agents and other research tools, molecular mechanism infringement claims, and protein therapies.
International Trade Commission (ITC) litigation: When it comes to ITC litigation, Finnegan was litigating IP cases at the ITC long before it became the popular forum it is today. Litigating in the ITC presents a unique challenge—litigating a technologically complicated case in a short period of time, in a pressure-packed forum that can make or break the commercial success of the products at issue. At the ITC, summary determination is rare, and approximately 45 percent of Section 337 cases go to trial, all in front of an Administrative Law Judge (ALJ), not a jury. So when choosing a firm to litigate in the ITC, trial experience in the ITC is of paramount importance. In the past five years, Finnegan attorneys have been involved in nearly 10 percent of Section 337 cases. Over 150 of the firm’s attorneys have litigated at the ITC. Finnegan also has practitioners with ITC experience in the chemical, pharmaceutical, and mechanical fields. Our attorneys have even tried ITC cases involving design patents and trademarks. During the past two years, more than half of all ITC cases have involved electrical and IT-related technologies and semiconductors; Finnegan has more than 80 lawyers and over 20 professionals who have at least one degree in electrical engineering, computer science, or some other related form of specialized technology.
Trademark litigation: Finnegan’s trademark litigation practice spans numerous industries and covers all types of trademark rights, including service marks, trade dress, product configuration, trade names, domain names, letters, numbers, colors, and telephone numbers. Representing both plaintiffs and defendants, our lawyers have decades of experience litigating both large and small trademark cases before courts throughout the country and regularly appear before the U.S. Patent and Trademark Office and its Trademark Trial and Appeal Board (TTAB), the federal circuit courts of appeal, district courts, and other tribunals. We have an impressive track record of favorably resolving litigations for our clients, whether by choosing a forum that gives clients the best chance to win on the law, filing a motion to dismiss, obtaining an early temporary restraining order or preliminary injunction, positioning a case for settlement, moving for summary judgment, or taking the case to trial. One of our strengths is the use of experts to enhance our clients’ legal positions. For many years, we have worked with numerous consumer survey experts on a wide range of issues in trademark litigation, including likelihood of confusion, likelihood of dilution, genericness, secondary meaning, and fame. We also make strategic use of other experts in areas such as linguistics, marketing, consumer psychology, industry practices, and damages.
North America: Atlanta, Boston, Palo Alto, Reston, and Washington, DC
Europe: London and Munich
Asia: Seoul, Shanghai, Taipei, and Tokyo.
Updated Aug 2022